Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caroline Cole Block, M.D.

Concepts (128)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms220211470.320 Why?
Aromatase Inhibitors220245130.260 Why?
Breast Neoplasms112024210170.260 Why?
Dihydrouracil Dehydrogenase (NADP)12024170.230 Why?
Acupuncture, Ear12022130.200 Why?
Cyclin-Dependent Kinase 6120243500.180 Why?
Filgrastim120201320.170 Why?
Cyclin-Dependent Kinase 4120245610.170 Why?
Receptors, Progesterone1202411290.160 Why?
Receptors, Estrogen2202422080.160 Why?
Pyridines2202428750.140 Why?
Carcinoma, Neuroendocrine120203390.140 Why?
Receptor, erbB-22202425570.130 Why?
Paclitaxel2202117320.130 Why?
Interdisciplinary Communication120219310.120 Why?
Antineoplastic Combined Chemotherapy Protocols32024117420.120 Why?
Polyethylene Glycols1202011890.120 Why?
Cyclophosphamide1202022200.120 Why?
Piperazines1202425230.110 Why?
Doxorubicin1202022240.110 Why?
Premenopause1201410390.090 Why?
Medical Oncology2202123210.090 Why?
Tamoxifen120149650.080 Why?
Nitriles120149710.080 Why?
Triazoles120149030.080 Why?
Thyroid Neoplasms1202023320.070 Why?
Spinal Cord Compression219992350.070 Why?
Benzimidazoles120118580.070 Why?
Antineoplastic Agents, Hormonal1201415200.060 Why?
Mammography1201224300.050 Why?
Premedication120212460.050 Why?
Phthalazines120233830.040 Why?
Antimetabolites, Antineoplastic120246460.040 Why?
Female1820243926860.040 Why?
Neoplasm Recurrence, Local3202392800.040 Why?
Fluorouracil1202416420.040 Why?
Proto-Oncogene Proteins c-ret120202250.040 Why?
Nausea120226790.040 Why?
Vomiting120226510.040 Why?
BRCA2 Protein120238050.040 Why?
Venous Thromboembolism1201118660.040 Why?
Early Detection of Cancer1201232010.040 Why?
Models, Statistical1201250790.040 Why?
Practice Guidelines as Topic2201273910.040 Why?
Feasibility Studies2202252470.040 Why?
BRCA1 Protein1202311580.030 Why?
Risk Assessment42012239960.030 Why?
Humans1920247615720.030 Why?
Thyroidectomy120209080.030 Why?
Germ-Line Mutation1202318580.030 Why?
Bone Marrow Transplantation2199226930.030 Why?
Lymphatic Metastasis1202129150.030 Why?
Pedigree1202045420.030 Why?
American Cancer Society12012690.030 Why?
Aged720241693100.030 Why?
Middle Aged920242209200.030 Why?
Spinal Neoplasms119997160.020 Why?
Antithrombin Proteins12011100.020 Why?
Ovarian Neoplasms1200948780.020 Why?
Ovariectomy120146140.020 Why?
Leukopenia119922130.020 Why?
Survival Analysis22021100900.020 Why?
Economics, Pharmaceutical12011870.020 Why?
Anemia, Hemolytic119921620.020 Why?
Neoplasm Metastasis1202149150.020 Why?
Biopsy1202167660.020 Why?
Combined Modality Therapy1202185280.020 Why?
Spinal Cord Diseases119922920.020 Why?
Risk Management120125580.020 Why?
Aged, 80 and over32024589860.020 Why?
Retrospective Studies52023806460.020 Why?
Gonadotropin-Releasing Hormone1201411480.020 Why?
Multivariate Analysis12021120590.020 Why?
Adult820242212030.020 Why?
Protein Kinase Inhibitors1202456720.020 Why?
Disease Progression12024135100.020 Why?
Proportional Hazards Models12021124630.020 Why?
Needs Assessment1201211390.020 Why?
Prospective Studies22021544260.020 Why?
Chemotherapy, Adjuvant1201435140.020 Why?
Medical History Taking120097740.020 Why?
Magnetic Resonance Imaging12012364290.020 Why?
Survival Rate22014127250.010 Why?
Thrombocytopenia1199211820.010 Why?
Body Mass Index12020129540.010 Why?
Case-Control Studies12020221760.010 Why?
Guideline Adherence1201222200.010 Why?
Phylogeny1200928110.010 Why?
Pandemics1202186560.010 Why?
Patient Selection1201242440.010 Why?
Neoplasm Staging12014111210.010 Why?
United States22021723350.010 Why?
Genetic Predisposition to Disease22012179040.010 Why?
Patient Education as Topic1200923190.010 Why?
Risk Factors32020742130.010 Why?
Cost-Benefit Analysis1201154920.010 Why?
Child, Preschool12020422300.010 Why?
Prognosis22014296290.010 Why?
Follow-Up Studies22014391070.010 Why?
Genetic Testing1200935370.010 Why?
Physician-Patient Relations1200932490.010 Why?
Cohort Studies22012414930.010 Why?
Male520243608420.010 Why?
Logistic Models21999132550.010 Why?
Young Adult12020592550.010 Why?
Mass Screening1200954280.010 Why?
Medical Records1199814080.010 Why?
Child12020801560.010 Why?
Blotting, Southern119927770.010 Why?
Polymorphism, Restriction Fragment Length119927670.010 Why?
Neurology119997800.010 Why?
Splenectomy119923910.010 Why?
Diagnosis, Differential21998129750.010 Why?
Quality of Life12011133670.010 Why?
Forecasting1199929280.010 Why?
Pain Measurement1199835510.000 Why?
Fluorescent Antibody Technique1199224680.000 Why?
Patient Care Team1199925210.000 Why?
Immunoglobulins, Intravenous119926640.000 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive119926860.000 Why?
Prednisone1199215630.000 Why?
Tomography, X-Ray Computed21999205710.000 Why?
Radiology1199921130.000 Why?
Chromosome Mapping1199246150.000 Why?
Palliative Care1199935980.000 Why?
Flow Cytometry1199258690.000 Why?
Leukemia, Myeloid, Acute1199236150.000 Why?
Adolescent11999883240.000 Why?
Block's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.